News
Citi lowered the firm’s price target on Bristol Myers (BMY) to $51 from $55 and keeps a Neutral rating on the shares. The stock is under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback